Question explored with the scientific record
Does the flu shot reduce mortality in elderly people?
The short version: the flu shot probably reduces all-cause mortality in the elderly by a small amount during flu season, but the evidence is almost entirely observational, funded by the same system that profits from the shot, and the size of the benefit is easily exaggerated by "healthy user" bias.
The question is about all-cause mortality in elderly people — not antibody titers, not lab-confirmed flu, not hospitalization. That is the right endpoint. The problem is that almost every study that claims a mortality benefit is observational, and observational studies comparing vaccinated to unvaccinated elderly are famously confounded by the "healthy user effect": people who get the shot are generally healthier, wealthier, and more health-conscious than those who don't. The one study that tried to adjust for this bias found the real mortality benefit was about 4.6% during flu season, not the 40-50% relative risk reductions the crude observational studies report [7]. A bias-adjusted meta-analysis of 14 cohort studies found that after correction, the all-cause mortality benefit was still significant but much smaller: odds ratio 0.64 (0.44 to 0.92) [2]. That is a real effect, but it is modest.
The only randomized trial in the evidence that directly tested mortality in elderly people was a cluster-randomized trial of vaccinating care home staff, not the residents themselves. In the season with high flu activity, resident mortality dropped from 15.3% to 11.2% — an absolute reduction of about 4 percentage points [8]. That is a meaningful effect, but it is indirect (herd protection from staff) and only replicated in one of two seasons. No large randomized trial has ever tested whether directly vaccinating elderly people reduces their all-cause mortality. The evidence base is built on observational studies that overstate the benefit.
| Study type | Reported relative risk reduction | Bias-adjusted estimate | Absolute risk context |
|---|---|---|---|
| Crude observational meta-analyses [1, 2] | 46-49% | OR 0.64 (0.44-0.92) after adjustment [2] | Background mortality ~5-15% per season |
| Single well-controlled observational study [7] | 4.6% during flu season | Same (adjusted for confounders) | Excess mortality ~7.8 per 1000 person-seasons |
| Cluster-RCT of staff vaccination [8] | ~4 percentage points absolute | Only RCT in evidence | 15.3% vs 11.2% in high-activity season |
My call: the flu shot likely reduces all-cause mortality in elderly people by a small but real amount during seasons with circulating flu, but the evidence is weaker and the benefit smaller than what is commonly claimed. The most informative study design — a randomized placebo-controlled trial with all-cause mortality as the endpoint in community-dwelling elderly — has never been done. Confidence: moderate that a small benefit exists, low on the exact size, and very low that it is worth the cumulative dose of annual injections over a lifetime given the absence of long-term safety data in this population.
Sources examined 23
-
Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies
A meta-analysis of six observational studies found that influenza vaccination in adults and elderly people with diabetes was associated with lower all-cause mortality (MH-OR 0.54, 95% CI 0.40-0.74) and lower hospitalization for pneumonia (MH-OR 0.89, 95% CI 0.80-0.98).
DOI: 10.3390/vaccines8020263 -
After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
A methodological meta-analysis comparing conventional and bias-adjusted approaches to estimating seasonal influenza vaccine effectiveness in community-dwelling elderly, showing that bias adjustment reduces heterogeneity and yields significant protection against hospitalization f…
DOI: 10.1016/j.jclinepi.2014.02.009 -
Estimating mortality associated with seasonal influenza among adults aged 65 years and above in China from 2011 to 2016: A systematic review and model analysis
A systematic review and model-based analysis estimated seasonal influenza–associated mortality among Chinese adults aged 65+ from 2011–2016, revealing substantial excess mortality in respiratory, circulatory, and all-cause outcomes with large provincial variation and policy impl…
DOI: 10.1111/irv.13067 -
Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients
This study investigates the impact of promoting influenza vaccination among healthcare workers on reducing influenza-related morbidity and mortality in elderly residents of long-term care facilities, demonstrating significant benefits during periods of influenza circulation.
DOI: 10.1371/journal.pone.0169023 -
O-050: Incidence of benzodiazepine and related drug use in persons with and without Alzheimer's disease: the MEDALZ study
This study systematically reviews the efficacy, safety, and tolerability of commonly prescribed urological drugs for treating lower urinary tract symptoms (LUTS) in elderly patients, finding significant associations between certain vaccinations and reduced all-cause mortality in…
DOI: 10.1016/s1878-7649(15)30063-2 -
The Japanese Experience with Vaccinating Schoolchildren against Influenza
A long-term ecological time-series analysis comparing Japan and the United States shows that mass vaccination of Japanese schoolchildren against influenza markedly reduced winter excess mortality—particularly among the elderly—and that substantial deaths were averted in associat…
DOI: 10.1056/NEJM200103223441204 -
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
This study investigates the impact of influenza vaccination on mortality among elderly members of Kaiser Permanente in Northern California, revealing a vaccine effectiveness of 4.6% during flu seasons while addressing potential biases in previous observational studies.
DOI: 10.1093/aje/kwp173 -
Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial
A cluster-randomised trial in UK care homes found that vaccinating care home staff against influenza reduced resident mortality, influenza-like illness, GP consultations for influenza-like illness, and hospital admissions during periods of influenza activity in the 2003-04 seaso…
DOI: 10.1136/bmj.39010.581354.55 -
Effectiveness of pneumococcal vaccination in reducing hospitalization and mortality among the elderly: A systematic review and meta-analysis
A systematic review and meta-analysis of 35 studies (1997–2024) evaluating pneumococcal vaccination in the elderly, finding reduced all-cause hospitalization with vaccines but mixed, highly heterogeneous effects on pneumonia-related hospitalization and mortality across subgroups…
DOI: 10.1080/21645515.2025.2561315 -
Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines
A comprehensive analysis of global HPAI H5 outbreaks (2019–2022) showing high HA1 homology between avian and human isolates and highlighting key receptor-binding mutations (137A, 192I, 193R) that may enable human infection, underscoring the need for H5-specific and universal inf…
DOI: 10.1038/s41421-023-00571-x -
Toward a better understanding of the relationship between influenza vaccine efficacy against specific and non-specific endpoints and vaccine efficacy against influenza infection
This study derives and analyzes a mathematical relationship between influenza vaccine effectiveness against specific/non-specific influenza-related endpoints (VE_E) and vaccine effectiveness against influenza infection (VE_I), showing VE_E can exceed VE_I under certain condition…
DOI: 10.2427/12367 -
Effect of Lymphocyte miRNA Expression on Influenza Vaccine-Induced Immunity
This study investigates the role of lymphocyte miRNA expression in predicting immune responses to influenza vaccination, identifying specific miRNAs that correlate with antibody responses and may serve as biomarkers for vaccine efficacy.
DOI: 10.1101/2024.11.02.24316654 -
The Relationship Between Influenza Vaccine-Induced Specific Antibody Responses and Vaccine-Induced Nonspecific Autoantibody Responses in Healthy Older Women
Age-related changes in humoral immunity show that elderly women have reduced influenza-specific antibody responses after vaccination but increased nonspecific autoantibody (anti-dsDNA) responses, with an inverse correlation between these processes.
DOI: 10.1093/geronj/47.2.M50 -
Global estimates of vaccine-associated narcolepsy from 1967 to 2023
This study provides global estimates of vaccine-associated narcolepsy from 1967 to 2023, identifying significant associations with specific vaccines, particularly influenza vaccines, and highlighting the need for improved vaccination protocols.
DOI: 10.1038/s41598-025-04049-6 -
Region-selective and site-specific glycation of influenza proteins surrounding the viral envelope membrane
Proteome-wide mapping shows region-selective, site-specific lysine glycation on influenza vaccine membrane proteins M1, HA, and NA, revealing targeted modifications with potential impacts on structure, receptor binding, and enzymatic activity that could serve as a quality attrib…
DOI: 10.1038/s41598-024-69793-7 -
Receptor specificity of influenza virus influences severity of illness in ferrets
In ferrets, a receptor-variant influenza clone with preferential SAα2,3 binding shows attenuated illness but similar immunogenicity compared with wild-type SAα2,6-binding influenza, suggesting receptor specificity can modulate virulence without compromising vaccine potential.
DOI: 10.1016/0264-410x(95)00004-k -
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization
In six adults vaccinated with seasonal influenza vaccine, peak circulating influenza-specific antibody-secreting cells (ASCs) correlated with the fold-rise in serum antibodies, and ASC kinetics served as an early biomarker of vaccine responsiveness.
DOI: 10.1016/j.vaccine.2010.02.088 -
Cytotoxic Vδ2+ T cell subsets expand in response to malaria in human tonsil and spleen organoids
A human lymphoid organoid model (tonsil and spleen) reveals that malaria exposure expands clonally proliferating, cytotoxic Vδ2+ γδ T cells within secondary lymphoid tissues, with in vivo Ugandan children showing similar cytotoxic Vδ2+ T cell phenotypes; malaria exposure did not…
DOI: 10.1101/2025.09.24.678447 -
Insight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus Hemagglutinin
This study identifies and characterizes highly conserved H1 subtype-specific epitopes in the hemagglutinin of influenza viruses, revealing potential targets for vaccine development and diagnostics.
DOI: 10.1371/journal.pone.0089803 -
A Tool for the Economic Analysis of Mass Prophylaxis Operations With an Application to H1N1 Influenza Vaccination Clinics
This study develops and tests a cost analysis tool for mass prophylaxis operations, specifically applied to H1N1 influenza vaccination clinics, to assist clinic managers in estimating operational costs and resource allocation.
DOI: 10.1097/PHH.0b013e3181f87952 -
Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice
The study shows that hemagglutinin receptor-binding site residues (226/228) modulate the immunogenicity and protective efficacy of H5N1 and H7N9 influenza vaccines in mice, with designs combining both avian- and mammalian-type receptor specificities yielding enhanced protection.
DOI: 10.1016/j.vaccine.2016.03.031 -
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
This study presents an optimized hemagglutination inhibition assay for quantifying influenza-specific antibody titers, demonstrating its application in assessing vaccine-induced immunity and cross-reactivity among different influenza strains.
DOI: 10.3791/55833 -
Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis
This systematic review of 17 studies in adults aged 65 and older found that intradermal influenza vaccination is more immunogenic than intramuscular or subcutaneous vaccination at equivalent doses, can be dose-spared down to 3 mcg hemagglutinin without loss of immunogenicity, el…
DOI: 10.3390/v14112438